Antibiotic resistance isn’t just a pharmaceutical problem
Researchers gathered at McMaster University on Friday to discuss the biological, societal and political contributions to antibiotic resistant bacteria, a concern the McMaster University’s Global Nexus has dubbed “ the next pandemic .”
Anti-microbial resistance (AMR) occurs when infection-causing pathogens — like bacteria, viruses, fungi and parasites — develop immunity or defences against medications that would otherwise kill them. This resistance allows the infection to spread at a rapid rate, as the medications clear out any competition from nonresistant strains. This phenomenon has led to the rise of “superbugs,” like MRSA (Methicillin-resistant Staphylococcus aureus).
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
